Connor, Clark & Lunn Investment Management (CC&L)’s Regenxbio RGNX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-13,515
| Closed | -$104K | – | 1573 |
|
|
2024
Q4 | $104K | Sell |
13,515
-47,773
| -78% | -$369K | ﹤0.01% | 1359 |
|
|
2024
Q3 | $643K | Buy |
+61,288
| New | +$643K | ﹤0.01% | 1023 |
|
|
2022
Q2 | – | Sell |
-44,751
| Closed | -$1.49M | – | 1181 |
|
|
2022
Q1 | $1.49M | Sell |
44,751
-20,936
| -32% | -$695K | 0.01% | 573 |
|
|
2021
Q4 | $2.15M | Sell |
65,687
-11,495
| -15% | -$376K | 0.01% | 509 |
|
|
2021
Q3 | $3.24M | Buy |
+77,182
| New | +$3.24M | 0.02% | 431 |
|
|
2018
Q4 | – | Sell |
-7,665
| Closed | -$579K | – | 1037 |
|
|
2018
Q3 | $579K | Buy |
+7,665
| New | +$579K | ﹤0.01% | 667 |
|